Study of HIV-related neuropsychological impairment: A review of methodological aspects;Estudio de la afectación neuropsicológica asociada al VIH: Revisión de aspectos metodológicos

Actas Espanolas de Psiquiatria

Volumn 31, Issue 2, 2003, Pages 79-84

  Rodríguez Álvarez, Maria ^a   Rodriguez Salgado D ^b  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^b NONE

Author keywords

HIV infection; Methodological problems; Methodological recommendations; Neuropsychological impairment

Indexed keywords

DISEASE ASSOCIATION; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; MEDICAL LITERATURE; MENTAL DISEASE; NEUROPSYCHOLOGICAL TEST; PATIENT SELECTION; REVIEW; SAMPLE SIZE; SAMPLING; STATISTICAL ANALYSIS;

COGNITION DISORDERS; HIV SEROPOSITIVITY; HUMANS; NEUROPSYCHOLOGICAL TESTS; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 0242600666     PISSN: 11399287     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. World Health Organization. Report of the second consultation on the neuropsychiatric aspects of HIV-1 infection. Paper presented at the Global Programme on AIDS, Geneva, Switzerland, 1990.
2. Janssen RS, Cornblath DR, Epstein LG, Foa RP, McArthur JC, Price, RW. Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Neurology 1991;41:778-85.
3. Marder K, Albert S, Dooneief G, Stern Y, Ramachandran G, Todak G, et al. Clinical confirmation of the American Academy of Neurology algorithm for HIV-1-associated cognitive/motor disorder. Neurology 1996;47:1247-53.
4. Rausch D, Stover ES. Neuroscience research in AIDS. Prog Neuropsychopharmacol Biol Psychiatry 2001;25:231-57.
5. Grant I, Atkinson JH. The evolution of neurobehavioral complications of HIV infection. Psychol Med 1990;20:747-54.
6. Grant I, Heaton RK. Human immunodeficiency virus-type 1 (HIV-1) and the brain. J Consult Clin Psychol 1990;58:22-30.
7. Markowitz JC, Perry SW. Effects of human immunodeficiency virus on the central nervous system. En: Yudofsky SC, Hales RE, editores. Textbook of neuropsychiatry. Washington, DC: American Psychiatric Press; p. 499-518.
8. Grant I, Martin A. Neuropsychology of HIV infection. New York: Oxford University Press, 1994.
9. Marcotte TD, Grant I, Atkinson JH, Heaton RK. Neurobehavioral complications of HIV infection. En: Tarter RE, Butters M, et al., editores. Medical neuropsychology. Clinical issues in neuropsychology. New York: Kluwer Academic/Plenum Publishers, 2001; p. 285-331.
10. Neufeld G, Bornstein RA. Neuropsychological and psychiatric aspects of HIV infection. En: Nott, KH, Vedhara K, editor. Psychosocial and biomedical interactions in HIV infection. Biobehavioural perspectives on health and disease prevention. Amsterdam: Harwood Academic Publishers, 2000; p. 103-35.
11. Newman SP, Lunn S, Harrison JG. Do asymptomatic HIV-seropositive individuals show cognitive deficit? AIDS 1995;9:1211-20.
12. Bornstein RA. Methodological and conceptual issues in the study of cognitive change in HIV infection. En: Grant I, Martin A, editores. Neuropsychology of HIV infection. New York: Oxford University Press, 1994; p. 146-60.
13. Van Gorp WG, Lamb DG, Schmitt FA. Methodologic issues in neuropsychological research with HIV-spectrum disease. Arch Clin Neuropsychol 1993;8:17-33.
14. Pereda M, Gómez del Barrio A, Ayuso Mateos JL. Problemas metodológicos en la evaluación del deterioro cognitivo asociado al VIH. Neurología 1999;14:452-8.
15. Basso MR, Bornstein RA. Neurobehavioural consequences of substance abuse and HIV infection. J Psychopharmacol 2000;14:228-37.
16. Wilkins JW, Robertson KR, Van Der Horst C, Robertson WT, Fryer JG, Hall CD. The importance of confounding factors in the evaluation of neuropsychological changes in patients infected with human immunodeficiency virus. J Acquir Immune Defic Syndr 1990;3:938-42.
17. Starace F, Baldassarre C, Biancolilli V, Fea M, Serpelloni G, Bartoli L, et al. Early neuropsychological impairment in HIV-seropositive intravenous drug users: evidence from the Italian Multicentre Neuropsychological HIV Study. Acta Psychiatr Scand 1998;97:132-8.
18. Pereda M, Ayuso Mateos JL, Gómez del Barrio A, Echevarría S, Farinas CM, García Palomo D, et al. Datos normativos para la exploración neuropsicológica de usuarios de drogas por vía parenteral. Actas Esp Psiquiatr 1998;26:363-70.
19. Stern Y. Neuropsychological evaluation of the HIV patient. Psychiatr Clin North Am 1994;17:125-34.
20. Clemente-Millana L, Portellano JA. Evaluación neuropsicológica de los déficit cognitivos en la infección por el virus de la inmunodeficiencia humana tipo 1 (VIH-1). Rev Neurol 2000;31:1192-201.
21. Adams MA, Ferraro FR. Acquired immnodeficiency syndrome dementia complex. J Clin Psychol 1997;53:767-78.
22. Sidtis JJ, Price RW. Early HIV-1 infection and the AIDS dementia complex. Neurology 1990;40:323-6.
23. Butters N, Grant I, Haxby J, Judd LL, Martin A, McClelland J, et al. Assessment of AIDS-related cognitive changes: recommendations of the NIMH workshop on neuropsychological assessment approaches. J Clin Exp Neuropsychol 1990;12:963-78.
24. White DA, Heaton RK, Monsch AU, The HNRC Group. Neuropsychological studies of asymptomatic human immunodeficiency virus-type-1 infected individuals. JINS 1995;1:304-15.
25. Martin A, Heyes MP, Salazar AM, Kampen DL, Williams J, Law WA, et al. Progressive slowing of reaction time and increasing cerebrospinal fluid concentrations of quinolinic acid in HIV-infected individuals. J Neuropsychiatry Clin Neurosci 1992;4:270-9.
26. Ayuso Mateos JL, Pereda M, Gómez del Barrio A, Echevarría S, Farinas MC, García Palomo D. Slowed reaction time in HIV-1 seropositive intravenous drug users without AIDS. Eur Neurol 2000;44:72-8.
27. McCaffrey RJ, Duff K, Westervelt HJ, Palav A, Weber M, Haase RF. Preliminary serial assessment findings with the Brief NIMH neuropsychological battery for HIV infection and AIDS. NYS Psychologist 2000;12:51-3.
28. Duff K, Westervelt HJ, McCaffrey RJ, Haase RF. Practice effects, test-retest stability, and dual baseline assessments with the California Verbal Learning Test in a HIV sample. Arch Clin Neuropsychol 2001;16:461-76.
29. Ingraham LJ, Aiken CB. An empirical approach to determining criteria for abnormality in test batteries with multiple measures. Neuropsychology 1996;10:120-4.
30. Heaton RK, Grant I, Butters N, White DA, Kirson D, Atkinson JH, et al. The HNRC 500-Neuropsychology of HIV infection at different disease stages. JINS 1995;1:231-51.
31. Grant I, Atkinson JH, Hesselink JR, Kennedy CJ, Richman DD, Spector SA, et al. Evidence for early central nervous system involvement in the acquired immunodeficiency syndrome (AIDS) and other human immunodeficiency virus (HIV) infections. Ann Intern Med 1987;107:828-36.
32. Grunseit AC, Perdices M, Dunbar N, Cooper DA. Neuropsychological function in asymptomatic HIV-1 infection: methodological issues. J Clin Exp Neuropsychol 1994;16:898-910.
33. Ingraham LJ, Bridge TP, Janssen R, Stover E, Mirsky AF. Neuropsychological effects of early HIV-1 infection: assessment and methodology. J Neuropsychiatry Clin Neurosci 1990;2:174-82.
34. Pereda M, Ayuso-Mateos JL, Gómez del Barrio A, Echevarría S, Farinas MC, García Palomo D, et al. Factors associated with neuropsychological performance in HIV-seropositive subjects without AIDS. Psychol Med 2000;30:205-17.
35. Stern Y, McDermott MP, Albert S, Palumbo D, Selnes OA. Factors associated with incident human immunodeficiency virus-dementia. Arch Neurol 2001;58:473-9.
36. Rodríguez Álvarez M, Vázquez Justo E. Influencia de factores relacionados con la infección en el rendimiento neuro-psicológico de seropositivos al VIH. Neurología 2002;17:328-36.
37. Vázquez Justo E, Rodríguez Álvarez M. Influencia de factores no relacionados con la infección en el rendimiento neuro-psicológico de seropositivos al VIH. Rev Neurol 2002;35:474-80.
38. Marder K, Stern Y, Malouf R, Tang M, Bell K, Dooneief G, et al. Neurologic and neuropsychological manifestations of human immunodeficiency virus infection in intravenous drug users without Acquired Immunodeficiency Syndrome. Arch Neurol 1992;49:1169-75.